Regent Pacific Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RPGLF research report →
Price Chart
About the company
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
- CEO
- Jamie Alexander Gibson
- IPO
- 1997
- Employees
- 17
- HQ
- Hong Kong, HK
Get TickerSpark's AI analysis on RPGLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.72M
- P/E
- -12.28
- PEG
- -0.21
- P/S
- 4.43
- P/B
- -3.97
- EV/EBITDA
- -34.74
- Div Yield
- 0.00%
- Gross Margin
- 92.53%
- Op Margin
- 1.35%
- Net Margin
- -36.02%
- ROE
- 30.76%
- ROIC
- 1.28%
Latest fiscal year · YoY change
- Revenue
- $348.51K-51.5%
- Gross Profit
- $340.50K+255.5%
- Op Income
- $-4,318,378
- Net Income
- $-4,716,967-5.2%
- EPS
- $-0.02+8.2%
- OCF Growth
- -3.9%
- FCF Growth
- -4.1%
- 52W High
- $0.43
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 1.06
- RSI (14)
- 1
- Avg Volume
- 22
No earnings-call transcripts are available for RPGLF yet.
- Free Float
- 0.5%
- Shares Outstanding
- 291.82M
- Float Shares
- 1.58M
Our RPGLF coverage
Recent articles, reports, and earnings notes.
No research on RPGLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RPGLF report →